Calidi Biotherapeutics, Inc. (CLDWW)

Every figure this model derived for CLDWW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2022-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 4,290,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 5,428,000 AssetsCurrent 2026-06-30
current liabilities 3,237,000 LiabilitiesCurrent 2026-06-30
equity 3,133,000 StockholdersEquity 2026-06-30
revenue 45,000 RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CLDWW on one particular measure came for.

RatioValue
current ratio1.68
current ratio reported1.68
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about CLDWW's figures. Written by the derivation as it ran, not added afterwards.